Beyond the Base Case: Mastering Sensitivity Analysis in Valuation
You are deep into your quarterly research report for a mid-cap pharmaceutical firm listed on the NSE. Your DCF model projects a robust target price, fueled by aggressive assumptions regarding the launch of a new generic...